Cara Therapeutics

Cara Therapeutics is a biopharmaceutical company focused on developing innovative therapies for chronic pruritus, a debilitating condition characterized by persistent itching. The company's mission is to transform the way pruritus is treated to improve the quality of life for millions of sufferers. Cara Therapeutics has developed KORSUVA®, the first and only FDA-approved treatment for moderate to severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. This innovative therapy highlights the company's commitment to addressing unmet needs in pruritus treatment.

Cara Therapeutics prioritizes a patient-centric approach in its research and development, striving to create a positive impact for both patients and stakeholders. The company's values are reflected in its dedication to developing innovative therapies, operating responsibly, and empowering its employees. Furthermore, Cara Therapeutics is actively involved in environmental and social responsibility initiatives, demonstrating its commitment to sustainability and making a lasting positive impact on the world.

Cara Therapeutics offers a hybrid work policy, combining "collaboration days" in the office with remote work flexibility, enabling employees to achieve optimal efficiency and a balance between in-person interaction and individual preference.

Cara Therapeutics is a biopharmaceutical company dedicated to improving the lives of patients suffering from chronic pruritus, or chronic itching. Their mission is to be a leader in the treatment of chronic pruritus, transforming the way it is treated and improving the quality of life for millions who suffer from this condition. Cara Therapeutics is committed to developing innovative therapeutics that address the unmet needs of pruritus sufferers and to creating value for all stakeholders, including patients, healthcare providers, shareholders, and employees.

Cara Therapeutics fosters a collaborative and inclusive environment where employees are encouraged to embrace curiosity and innovation. They value patient-centricity, accountability, teamwork, and respect for individual contributions, creating a fun and engaging workplace. Their commitment to transparency and trust encourages open dialogue and supports personal and professional growth.

Cara Therapeutics prioritizes a respectful, diverse, equitable, and inclusive working environment, recognizing that each employee's expertise is crucial to their success. Their "P.A.T.I.E.N.T." values emphasize collaboration and trust, fostering a culture where colleagues from various backgrounds work seamlessly together to achieve their shared goal of improving patients' lives. Cara Therapeutics recognizes the importance of a hybrid work model, offering flexibility for remote work while maintaining a commitment to in-person collaboration days to enhance teamwork and ensure everyone feels empowered to contribute.